12 research outputs found

    System Biology and Machine Learning Framework for Prostate Cancer Survival Prediction

    Get PDF
    Prostate cancer (PC) is the most commonly diagnosed and the second most lethal malignancy in men. Proper understanding about the factors influencing the disease mechanism, response to the treatment and long term survival could facilitate effective disease management, treatment planning and decision making. Previous research initiatives reported a number of genes having impact on PC development but their genetic influence on the overall survival of the patients is still obscure. In this study, we fist identified PC related signature genes by analysing the RNA-seq transcriptomic data. Then we investigated the influence of those genes on the survival of PC patients using the clinical and transcriptomic data from the Cancer Genome Atlas (TCGA). Considering the univariate and multivariate analysis using the Cox proportional-hazards (CoxPH) model, we evidenced notable variation in the survival period between the altered and normal groups for two genes (APLN, and DUOXA1). We also identified ten hub genes such as CAV1, RHOU, TUBB4A, RRAS, EFNB1, ZWINT, MYL9, PPP3CA, FGFR2 and GATA3 in protein-protein interaction analysis that could be the source of potential therapeutic intervention. Moreover, several significant molecular pathways through functional enrichment analysis was obtained. After verification through functional studies, the identified genetic determinants could serve as therapeutic target for prolonged PC survival

    Genomic selection for wheat blast in a diversity panel, breeding panel and full-sibs panel

    Get PDF
    Wheat blast is an emerging threat to wheat production, due to its recent migration to South Asia and Sub-Saharan Africa. Because genomic selection (GS) has emerged as a promising breeding strategy, the key objective of this study was to evaluate it for wheat blast phenotyped at precision phenotyping platforms in Quirusillas (Bolivia), Okinawa (Bolivia) and Jashore (Bangladesh) using three panels: (i) a diversity panel comprising 172 diverse spring wheat genotypes, (ii) a breeding panel comprising 248 elite breeding lines, and (iii) a full-sibs panel comprising 298 full-sibs. We evaluated two genomic prediction models (the genomic best linear unbiased prediction or GBLUP model and the Bayes B model) and compared the genomic prediction accuracies with accuracies from a fixed effects model (with selected blast-associated markers as fixed effects), a GBLUP + fixed effects model and a pedigree relationships-based model (ABLUP). On average, across all the panels and environments analyzed, the GBLUP + fixed effects model (0.63 卤 0.13) and the fixed effects model (0.62 卤 0.13) gave the highest prediction accuracies, followed by the Bayes B (0.59 卤 0.11), GBLUP (0.55 卤 0.1), and ABLUP (0.48 卤 0.06) models. The high prediction accuracies from the fixed effects model resulted from the markers tagging the 2NS translocation that had a large effect on blast in all the panels. This implies that in environments where the 2NS translocation-based blast resistance is effective, genotyping one to few markers tagging the translocation is sufficient to predict the blast response and genome-wide markers may not be needed. We also observed that marker-assisted selection (MAS) based on a few blast-associated markers outperformed GS as it selected the highest mean percentage (88.5%) of lines also selected by phenotypic selection and discarded the highest mean percentage of lines (91.8%) also discarded by phenotypic selection, across all panels. In conclusion, while this study demonstrates that MAS might be a powerful strategy to select for the 2NS translocation-based blast resistance, we emphasize that further efforts to use genomic tools to identify non-2NS translocation-based blast resistance are critical

    Performance comparison of fuzzy queries on fuzzy database and classical database

    No full text
    In this paper we have designed a sample fuzzy database and we have applied both classical and fuzzy query on this fuzzy database. We have also shown that the time cost of fuzzy query on classical database (DB) is the same as the classical query on classical DB. But the time cost of the fuzzy query on sample fuzzy database has been reduced

    Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes

    No full text
    The ongoing COVID-19 outbreak, caused by SARS-CoV-2, has posed a massive threat to global public health, especially to people with underlying health conditions. Type 2 diabetes (T2D) is lethal comorbidity of COVID-19. However, its pathogenetic link remains unclear. This research aims to determine the genetic factors and processes contributing to the synergistic severity of SARS-CoV-2 infection among T2D patients through bioinformatics approaches. We analyzed two sets of transcriptomic data of SARS-CoV-2 infection obtained from lung epithelium cells and PBMCs, and two sets of T2D data from pancreatic islet cells and PBMCs to identify the associated differentially expressed genes (DEGs) followed by their functional enrichment analyses in terms of protein-protein interaction (PPI) to detect hub-proteins and associated comorbidities, transcription factors (TFs), microRNAs (miRNAs) as well as the potential drug candidates. In PPI analysis, four potential hub-proteins (i.e., BIRC3, C3, MME, and IL1B) were identified among 25 DEGs shared between the disease pair. Enrichment analyses using the mutually overlapped DEGs revealed the most prevalent GO and cell signalling pathways, including TNF signalling, cytokine-cytokine receptor interaction, and IL-17 signalling, which are related to cytokine activities. Furthermore, as significant TFs, we identified IRF1, KLF11, FOSL1, and CREB3L1 while miRNAs including miR-1-3p, 34a-5p, 16-5p, 155-5p, 20a-5p, and let-7b-5p were found to be noteworthy. The findings illustrated the significant association between COVID-19 and T2D at the molecular level. These genetic determinants can further be explored for their specific roles in disease progression and therapeutic intervention, while significant pathways can also be studied as molecular checkpoints. Finally, the identified drug candidates may be evaluated for their potency to minimize the severity of COVID-19 patients with pre-existing T2D

    System biology and bioinformatics pipeline to identify comorbidities risk association: Neurodegenerative disorder case study.

    No full text
    Alzheimer's disease (AD) is the commonest progressive neurodegenerative condition in humans, and is currently incurable. A wide spectrum of comorbidities, including other neurodegenerative diseases, are frequently associated with AD. How AD interacts with those comorbidities can be examined by analysing gene expression patterns in affected tissues using bioinformatics tools. We surveyed public data repositories for available gene expression data on tissue from AD subjects and from people affected by neurodegenerative diseases that are often found as comorbidities with AD. We then utilized large set of gene expression data, cell-related data and other public resources through an analytical process to identify functional disease links. This process incorporated gene set enrichment analysis and utilized semantic similarity to give proximity measures. We identified genes with abnormal expressions that were common to AD and its comorbidities, as well as shared gene ontology terms and molecular pathways. Our methodological pipeline was implemented in the R platform as an open-source package and available at the following link: https://github.com/unchowdhury/AD_comorbidity. The pipeline was thus able to identify factors and pathways that may constitute functional links between AD and these common comorbidities by which they affect each others development and progression. This pipeline can also be useful to identify key pathological factors and therapeutic targets for other diseases and disease interactions
    corecore